Anti-Mouse CD21/CD35 PE-Cy7

Also known as: CR2/CR1, C3DR

Clone: eBio8D9 (8D9)

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 25-0211

Cat. No. Size
25-0211-80 25 ug
25-0211-82 100 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Mouse CD21/CD35 PE-Cy7.

Staining of C57BL/6 splenocytes with Anti-Human/Mouse CD45R (B220) FITC (cat. 11-0452) and 0.06 ug...View More

  • Data for Anti-Mouse CD21/CD35 PE-Cy7.
Description

Description: The monoclonal antibody eBio8D9 reacts with an eptiope shared by mouse CD21 (CR2) and CD35 (CR1). CD21 and CD35 are alternatively spliced transcripts from the Cr2 gene, which produce cell-surface proteins of 145 and 190 kDa, respectively. CD21 and CD35 are expressed by mature B cells, but not on thymocytes, peripheral T cells, erythrocytes or platelets. Furthermore, there is some evidence which demonstrates their expression on macrophages. CD21 is a receptor for the complement component C3d and Epstein-Barr virus (EBV). In association with CD19 and CD81, CD21 also participates in B-cell activation through the B cell receptor. Cr2-deficient mice display impaired inflammatory and humoral immune responses in vivo.

The anti-mouse CD21/35 monoclonal antibody clones eBio4E3 and eBio8D9 do not cross-block each other, suggesting that they bind to different epitopes.

Details
Host Rat
Isotype IgG2a, lambda
Reactivity Mouse
Conjugate PE-Cy7
Laser Blue Laser, Green Laser, Yellow-Green Laser
Emit 760 nm
Excite 488 - 561 nm
Legal FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT FOR THERAPEUTIC OR IN VIVO APPLICATIONS. OTHER USE NEEDS LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. UNDER U.S. PATENT FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT FOR THERAPEUTIC OR IN VIVO APPLICATIONS. OTHER USE NEEDS LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. UNDER U.S. PATENT # 5,268,486, 5,569,587 AND 5,627,027 AND FOREIGN EQUIVALENTS AND PENDING APPLICATIONS. THIS MATERIAL IS SUBJECT TO PROPRIETARY RIGHTS OF GE HEALTHCARE BIO-SCIENCES CORP. AND CARNEGIE MELLON UNIVERSITY AND MADE AND SOLD UNDER LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. THIS PRODUCT IS LICENSED FOR SALE ONLY FOR RESEARCH. IT IS NOT LICENSED FOR ANY OTHER USE. THERE IS NO IMPLIED LICENSE HEREUNDER FOR ANY COMMERCIAL USE. COMMERCIAL USE shall include: 1. sale, lease, license or other transfer of the material or any material derived or produced from it; 2. sale, lease, license or other grant of rights to use this Material or any material derived or produced from it; 3. use of this material to perform services for a fee for third parties. IF YOU REQUIRE A COMMERCIAL LICENSE TO USE THIS MATERIAL AND DO NOT HAVE ONE, RETURN THIS MATERIAL, UNOPENED TO EBIOSCIENCE, INC. 10255 SCIENCE CENTER DRIVE, SAN DIEGO, CALIFORNIA 92121 USA AND ANY MONEY PAID FOR THE MATERIAL WILL BE REFUNDED.
Reported Applications Flow Cytometric Analysis
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
13-0211 Anti-Mouse CD21/CD35 Biotin FC RUO
12-0211 Anti-Mouse CD21/CD35 PE 488 - 561 nm 575 nm FC RUO
14-0211 Anti-Mouse CD21/CD35 Purified FC, FA, WB RUO
47-0211 Anti-Mouse CD21/CD35 APC-eFluor® 780 633 nm 780 nm FC RUO
11-0211 Anti-Mouse CD21/CD35 FITC 488 nm 518 nm FC RUO
References

References: Kozono Y, Abe R, Kozono H, Kelly RG, Azuma T, and Holers VM. 1998. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. Journal of Immunology. 160: 1565-1572. (8D9, FA, PubMed)

Martin, B.K., and J.H. Weis. Murine macrophages lack expression of the Cr2-145 (CR2) and Cr2-190 (CR1) gene products. Eur. J. Immunol. 993. 23: 3037-3042.


View More Products

AntigensArea of BiologyCell TypeFormats